Neurochemical Journal

, Volume 12, Issue 1, pp 71–77 | Cite as

The Influence of Noopept on Morphological, Electrophysiological, and Biochemical Changes in the Retina during the Experimental Thrombosis of Its Vessels

  • A. V. Kolesnikov
  • A. V. Shchul’kin
  • M. V. Pisklova
  • O. I. Barenina
  • E. N. Yakusheva
  • V. S. Kudrin
  • R. U. Ostrovskaya
  • M. G. Uzbekov
  • M. M. Shishkin
Experimental Articles


We studied the influence of the neuroprotective dipeptide drug noopept on the state of the retina during thrombosis of its vessels in an experiment with male chinchilla rabbits. The pathology was modeled by intravenous injection of rose Bengal at a dose of 40 mg/kg followed by transpupillary focal illumination with white light of the temporal vascular arcade for 10 min. Noopept was administered intravenously immediately after modeling thrombosis at a dose of 0.5 mg/kg, and then three times per day per os at a dose of 10 mg/kg throughout the experiment. It was found that noopept improves the functional state of the retinal neurons according to electroretinography. At the 5–7th and 14th days, noopept reduced the glutamate content in the retina by 86.8% and 84.1% compared to the control animals (p < 0.05), decreased the concentration of products of reaction with thiobarbituric acid by 17.3% and 14.9% on the 3rd and 7th days (p < 0.05), and increased the activity of glutathione-S-transferase by 34.5% on the 1st day (p < 0.05).


noopept photoinduced retinal vascular thrombosis glutamate excitotoxicity oxidative stress ischemia modeling 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    David, R., Zangwill, L., Badarna, M., and Yassur, Y., Ophthalmol., 1988, vol. 197, no. 2, pp. 69–74.CrossRefGoogle Scholar
  2. 2.
    Tul’tseva, S.N. and Astakhov, Yu.S., Okklyuzii ven setchatki (etiologiya, patogenez, klinika, diagnostika, lechenie) (Occlusion of Retina Veins (Etiology, Pathogenesis, Clinics, Diagnostics, and Treatment), St. Petersburg: N-L, 2010.Google Scholar
  3. 3.
    Glacet-Bernard, A., Coscas, G., Chabanel, A., Zourdani, A., Lelong, F., and Samama, M.M., Ophthalmol., 1996, vol. 103, pp. 551–560.CrossRefGoogle Scholar
  4. 4.
    Ostrovskaya, R.U., Gudasheva, T.A., Voronina, T.A., and Seredenin, S.B., Eksper. Klin. Farmakol., 2002, vol. 65, no. 5, pp. 66–72.Google Scholar
  5. 5.
    Us, K.S., Klodt, P.M., Kudrin, V.S., Sapronova, A.Ya., Ostrovskaya, R.U., Ugryumov, M.V., and Raevskii, K.S., Neirokhimiya, 2006, vol. 23, no. 2, pp. 122–127.Google Scholar
  6. 6.
    Kolesnikov, A.V., Shchul’kin, A.V., Yakusheva, E.N., Barenina, O.I., Uzbekov, M.G., Kudrin, V.S, Klodt, P.M., and Ostrovskaya, R.U., Neirokhimiya, 2016, vol. 33, no. 2, pp. 164–168.Google Scholar
  7. 7.
    Gavrilova, V.B., Gavrilova, A.R., and Mazul, L.M., Vopr. Med. Khim., 1987, no. 1, pp. 118–120.Google Scholar
  8. 8.
    Ellman, G.L., Arch. Biochem. Biophys., 1959, vol. 82, no. 1, pp. 70–77.CrossRefPubMedGoogle Scholar
  9. 9.
    Lankin, V.Z. and Gurevich, S.M., Dokl. Akad. Nauk SSSR, 1976, vol. 226, no. 3, pp. 705–708.PubMedGoogle Scholar
  10. 10.
    Keen, J.H. and Jakoby, W.B., J. Biol. Chem., 1978, vol. 253, no. 16, pp. 5654–5657.PubMedGoogle Scholar
  11. 11.
    Kostyuk, V.A., Potapovich, A.I., and Kovaleva, Zh.V., Vopr. Med. Khim., 1990, vol. 36, no. 2, pp. 88–91.Google Scholar
  12. 12.
    Pearson, S.J., Czudek, C., Mercer, K., and Reynolds, G.P., J. Neuronal. Transm., 1991, vol. 86, pp. 151–157.CrossRefGoogle Scholar
  13. 13.
    Glants, S., Mediko-biologicheskaya statistika. (Medical-Biological Statistics), Moscow: Praktika, 1998.Google Scholar
  14. 14.
    Shamshinova, A.M. and Volkov, V.V., Funktsional’nye metody issledovaniya v oftal’mologii (Functional Methods of Studies in Ophthalmology), Moscow: Meditsina, 1999.Google Scholar
  15. 15.
    Zueva, M.V. and Tsapenko, I.V., Klinicheskaya fiziologiya zreniya. Sb. nauch. trudov MNII GB im. Gel’mgol’tsa (Clinical Physiology of Vision. Proceedings of Helmholtz MNII GB), Moscow: Russomed, 1993.Google Scholar
  16. 16.
    Gundorova, R.E., Shvetsova, N.E., Ivanov, A.N., Tsapenko, I.V., Fedorov, A.A., Zueva, M.V., Tankovskii, V.E., and Ryabina, M.V., Vestn. Oftal’mol., 2008, vol. 124, no. 3, pp. 18–22.Google Scholar
  17. 17.
    Louzada-Junior, P., Dias, J.J., Santos, W.F., Lachat, J.J., Bradford, T.F., and Coutinho-Netto, J., J. Neurochem., 1992, vol. 59, pp. 358–363.CrossRefPubMedGoogle Scholar
  18. 18.
    Kowluru, R.A., Engerman, R.L., Case, G.L., and Kern, T.S., Neurochem. Internat., 2001, vol. 38, no. 5, pp. 385–390.CrossRefGoogle Scholar
  19. 19.
    Sharma, R.K. and Ehinger, B., Adler’s Physiology of the Eye: Clinical Application, Kaufman, P.L. and Alm, A., Eds., St. Louis: Mosby, 2003, pp. 319–347.Google Scholar
  20. 20.
    Gilgun, SherkiY., Rosenbaum, Z., Melamed, E., and Offen, D., Pharmacol. Rev., 2002, vol. 54, no. 2, pp. 271–284.CrossRefGoogle Scholar
  21. 21.
    Kalinina, E.V., Chernov, N.N., and Saprin, A.N., Usp. Biol. Khim., 2008, vol. 48, pp. 319–358.Google Scholar
  22. 22.
    Gudasheva, T.A., Vestn. Ross. Akad. Med. Nauk, 2011, no. 7, pp. 8–16.Google Scholar
  23. 23.
    Vakhitova, Yu.V., Sadovnikov, S.V., Borisevich, S.S., Ostrovskaya, R.U., Gudasheva, T.A., and Seredenin, S.B., Acta Naturae, 2016, vol. 8, no. 1, pp. 90–98.Google Scholar

Copyright information

© Pleiades Publishing, Ltd. 2018

Authors and Affiliations

  • A. V. Kolesnikov
    • 1
  • A. V. Shchul’kin
    • 1
    • 5
  • M. V. Pisklova
    • 2
  • O. I. Barenina
    • 1
  • E. N. Yakusheva
    • 1
  • V. S. Kudrin
    • 2
  • R. U. Ostrovskaya
    • 2
  • M. G. Uzbekov
    • 3
  • M. M. Shishkin
    • 4
  1. 1.Ryazan State Medical UniversityRyazanRussia
  2. 2.Zakusov Institute of PharmacologyMoscowRussia
  3. 3.Moscow Institute of PsychiatryMinistry of HealthMoscowRussia
  4. 4.Pirogov National Medical Surgery CenterMinistry of HealthMoscowRussia
  5. 5.RyazanRussia

Personalised recommendations